Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D De Wit

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
International Journal of Endocrinology|August 22, 2015
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II TrialT C Schneider, D de Wit, T P Links, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2016
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancerD de Wit, T C Schneider, D J A R Moes, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 28, 2020
COVID-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathyJ E Mongula, M W E Frenken, G van Lijnschoten, et al.
Frontiers in Medicine|August 10, 2018
A Conceptual Framework for Optimizing Blood Matching Strategies: Balancing Patient Complications Against Total Costs IncurredJoost H J van Sambeeck, Puck D de Wit, Jessie Luken, et al.
BMC Pregnancy and Childbirth|October 12, 2010
Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study)Denise H J Delahaije, Sander M J van Kuijk, Carmen D Dirksen, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
International Journal of Endocrinology|August 22, 2015
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II TrialT C Schneider, D de Wit, T P Links, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2016
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancerD de Wit, T C Schneider, D J A R Moes, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 28, 2020
COVID-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathyJ E Mongula, M W E Frenken, G van Lijnschoten, et al.
Frontiers in Medicine|August 10, 2018
A Conceptual Framework for Optimizing Blood Matching Strategies: Balancing Patient Complications Against Total Costs IncurredJoost H J van Sambeeck, Puck D de Wit, Jessie Luken, et al.
BMC Pregnancy and Childbirth|October 12, 2010
Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study)Denise H J Delahaije, Sander M J van Kuijk, Carmen D Dirksen, et al.
Pageof 6